Bora Pharmaceuticals
Ning Zhang is a seasoned professional in quality control and tech transfer, currently serving as Sr. Manager of QC and Tech Transfer at Bora Pharmaceuticals since August 2024. Prior experience includes leadership roles in QC at Emergent BioSolutions from July 2017 to September 2024, where responsibilities encompassed managing both tech transfer and QC Analytical groups and overseeing a growing team of analysts. Earlier positions at Pharmaceutical International Inc. and the University of Maryland included design and implementation of testing protocols and research on liposome vesicles, respectively. Ning Zhang holds a Ph.D. in Chemistry and Biochemistry from the University of Maryland Baltimore County, completed in 2005.
This person is not in any teams
This person is not in any offices
Bora Pharmaceuticals
Bora Pharmaceuticals is a premier international contract development and manufacturing organization (CDMO) specializing in complex oral solid dose, liquids, semi-solids, ophthalmics and nasal sprays for pharmaceutical Rx and OTC products. We operate from early phase clinical right through to commercial manufacturing with full packaging capabilities. From cell-line development and formulation to analytical services and clinical cGMP manufacturing, Bora now provides tailored development and manufacturing services to biologics developers. Bora owns and operates in six state-of-the-art CGMP manufacturing facilities across Asia and North America – delivering to more than 100 markets around the world. Our sites have the highest international standards for manufacturing, packaging, R&D and analytical testing. As a future focused CDMO, we know better than most that our own success is shaped by our partners victories. That's why, when you choose Bora - we make success more certain by following Bora’s 5Ps – Promises, Partnerships, Pride, People, and Progress. These 5 principles are Bora’s Pledge to our customers. Follow us to find out more and keep up to date with Bora Pharmaceuticals.